Partial nephrectomy as a model for uremic cardiomyopathy in the mouse
- PMID: 18032546
- PMCID: PMC2742580
- DOI: 10.1152/ajprenal.00472.2007
Partial nephrectomy as a model for uremic cardiomyopathy in the mouse
Abstract
Because of the plethora of genetic manipulations available in the mouse, we performed a partial nephrectomy in the mouse and examined whether the phenotypical features of uremic cardiomyopathy described in humans and rats were also present in the murine model. A 5/6 nephrectomy was performed using a combination of electrocautory to decrease renal mass on the left kidney and right surgical nephrectomy. This procedure produced substantial and persistent hypertension as well as increases in circulating concentrations of marinobufagenin. Invasive physiological measurements of cardiac function demonstrated that the 5/6 nephrectomy resulted in impairment of both active and passive left ventricular relaxation at 4 wk whereas tissue Doppler imaging detected changes in diastolic function after 6 wk. Morphologically, hearts demonstrated enlargement and progressive fibrosis, and biochemical measurements demonstrated downregulation of the sarcoplasmic reticulum calcium ATPase as well as increases in collagen-1, fibronectin, and vimentin expression. Our results suggest that partial nephrectomy in the mouse establishes a model of uremic cardiomyopathy which shares phenotypical features with the rat model as well as patients with chronic renal failure.
Figures
Similar articles
-
Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy.Hypertension. 2006 Mar;47(3):488-95. doi: 10.1161/01.HYP.0000202594.82271.92. Epub 2006 Jan 30. Hypertension. 2006. PMID: 16446397
-
Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2096-108. doi: 10.1152/ajpheart.00452.2009. Epub 2009 Oct 2. Am J Physiol Heart Circ Physiol. 2009. PMID: 19801494
-
Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy.Hypertension. 2007 Jan;49(1):215-24. doi: 10.1161/01.HYP.0000252409.36927.05. Epub 2006 Dec 4. Hypertension. 2007. PMID: 17145984
-
Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.Expert Opin Ther Targets. 2017 May;21(5):531-541. doi: 10.1080/14728222.2017.1311864. Epub 2017 Apr 3. Expert Opin Ther Targets. 2017. PMID: 28338377 Free PMC article. Review.
-
Uremic cardiomyopathy and insulin resistance: a critical role for akt?J Am Soc Nephrol. 2011 Feb;22(2):207-15. doi: 10.1681/ASN.2009090900. Epub 2010 Jul 15. J Am Soc Nephrol. 2011. PMID: 20634295 Review.
Cited by
-
Cardiovascular changes in the NZB/W F1 mouse model of lupus nephritis.Front Cardiovasc Med. 2023 Jul 24;10:1182193. doi: 10.3389/fcvm.2023.1182193. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37554366 Free PMC article.
-
New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases.Int J Mol Sci. 2023 Jul 6;24(13):11186. doi: 10.3390/ijms241311186. Int J Mol Sci. 2023. PMID: 37446363 Free PMC article. Review.
-
Novel Model of Oxalate Diet-Induced Chronic Kidney Disease in Dahl-Salt-Sensitive Rats.Int J Mol Sci. 2023 Jun 13;24(12):10062. doi: 10.3390/ijms241210062. Int J Mol Sci. 2023. PMID: 37373209 Free PMC article.
-
Dietary choline, via gut microbe- generated trimethylamine-N- oxide, aggravates chronic kidney disease-induced cardiac dysfunction by inhibiting hypoxia-induced factor 1α.Front Physiol. 2022 Nov 3;13:996166. doi: 10.3389/fphys.2022.996166. eCollection 2022. Front Physiol. 2022. PMID: 36407000 Free PMC article.
-
Six Decades of History of Hypertension Research at the University of Toledo: Highlighting Pioneering Contributions in Biochemistry, Genetics, and Host-Microbiota Interactions.Curr Hypertens Rep. 2022 Dec;24(12):669-685. doi: 10.1007/s11906-022-01226-0. Epub 2022 Oct 27. Curr Hypertens Rep. 2022. PMID: 36301488 Free PMC article. Review.
References
-
- Dostanic-Larson I, Lorenz JN, Van Huysse JW, Neumann JC, Moseley AE, Lingrel JB. Physiological role of the α1- and α2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site. Am J Physiol Regul Integr Comp Physiol. 2006;290:R524–R528. - PubMed
-
- Elkareh J, Kennedy DJ, Yashaswi B, Vetteth S, Shidyak A, Kim EG, Smaili S, Periyasamy SM, Hariri IM, Fedorova L, Liu J, Wu L, Kahaleh MB, Xie Z, Malhotra D, Fedorova OV, Kashkin VA, Bagrov AY, Shapiro JI. Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension. 2007;49:215–224. - PubMed
-
- Gagnon RF, Duguid WP. A reproducible model for chronic renal failure in the mouse. Urol Res. 1983;11:11–14. - PubMed
-
- Kennedy D, Omran E, Periyasamy SM, Nadoor J, Priyadarshi A, Willey JC, Malhotra D, Xie Z, Shapiro JI. Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J Am Soc Nephrol. 2003;14:90–97. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
